CoChat

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure

Open access
Stella-Ascariz, Natalia, Arribas, José Ramón, Paredes, Roger, Li, Jonathan Z · 2017 · The Journal of Infectious Diseases
Cited by 62

The DOI matches its Crossref record.

Abstract

Human immunodeficiency virus type 1 (HIV-1) drug resistance genotyping is recommended to help in the selection of antiretroviral therapy and to prevent virologic failure. There are several ultrasensitive assays able to detect HIV-1 drug-resistance minority variants (DRMVs) not detectable by standard population sequencing-based HIV genotyping assays. Presence of these DRMVs has been shown to be clinically relevant, but its impact does not appear to be uniform across drug classes. In this review, we summarize key evidence for the clinical impact of DRMVs across drug classes for both antiretroviral treatment-naive and antiretroviral treatment-experienced patients, and highlight areas where more supporting evidence is needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jix430

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 62

Metadata

Authors
Stella-Ascariz, N., Arribas, J. R., Paredes, R., & Li, J. Z.
Venue
The Journal of Infectious Diseases
Published
2017-11-15
Volume
216
Issue
suppl_9
Pages
S847-S850
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2774431833
Cited by
62
References
0
FWCI
4.05
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure. https://app.cochat.ai/papers/10.1093/infdis/jix430
The paper
Stella-Ascariz, N., Arribas, J. R., Paredes, R., & Li, J. Z. (2017). The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jix430

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.